Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis
The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.
Bio-Rad Laboratories, NuProbe USA Ink Licensing and Development Agreement
NuProbe will exclusively license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays.
DiaSorin Gets FDA Clearance for Test to Differentiate Bacterial, Viral Infections
The Liaison MeMed BV assay can help determine whether a patient's infection is caused by a bacterial or viral pathogen.
Wyss Institute Licenses Electrochemical Sensing Technology to StataDx
StataDx has obtained a license to eRapid, an affinity-based, multiplexed, electrochemical sensing technology developed at Harvard's Wyss Institute.
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.
Jul 30, 2021
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
Oct 22, 2020
Danaher Q3 Revenues Up 35 Percent
Mar 4, 2020
Randox Laboratories STI Assay Gets CE Mark
May 9, 2019
NanoString Revenues Climb 18 Percent in Q1
Jan 16, 2019
First Light Diagnostics Raises $8.25M
Jul 16, 2018
Biomarker-Based Dx Firm Kypha Buys Biosensia
Jun 29, 2018
Apr 19, 2018
Mobidiag Gets CE Marks for Two Tests
Feb 14, 2018